Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023335171> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2023335171 endingPage "215" @default.
- W2023335171 startingPage "207" @default.
- W2023335171 abstract "Cryogel is a physical gel formed by the heterophilic aggregation of extra domain A (EDA) containing fibronectin [EDA(+)FN], plasma fibronectin (pFN), fibrinogen (Fbg) and heparin (Hep) in the blood of rheumatoid arthritis (RA) patients. In cryogelation EDA(+)FN cross-links to form an interaggregate of cryogel with Hep. In the present study, we determined the recognition structure of Hep for EDA(+)FN by using oligo- and desulfonated-Hep. The affinity constant (KA) (1.2×108 per M) of oligo-Hep for EDA(+)FN did not change with a decrease in number-average molecular weight (4.9×104→6.0×103). The KA-value of desulfonated-Hep for EDA(+)FN decreased from 3.2×108 to 1.0×107 per M with a decrease in the sulfonation ratio (7.0→4.3%). We also determined the recognition structure of EDA(+)FN for Hep by an inhibition experiment on the heparin binding domain II (HepII) in EDA(+)FN with the synthetic peptides, Arg–Arg–Ala–Arg (RRAR), Asp–Gln–Ala–Arg (DNAR), Ile–Lys–Tyr–Glu–Lys (IKYEK), and Gly–Arg–Lys–Lys–Try (GRKKT). The GRKKT sequence clearly inhibited bonding between EDA(+)FN and Heps containing oligo- and desulfonated-Hep. The amount of cryogel formed in the RA-patient model plasma corresponded to the EDA(+)FN concentration in cryogel (36.7%) normalized by the EDA(+)FN concentration in plasma. When GRKKT was added to plasma, the EDA(+)FN concentration fell to 10.5%. These results demonstrated that inhibition of cryogelation in plasma could progress to a novel treatment for RA." @default.
- W2023335171 created "2016-06-24" @default.
- W2023335171 creator A5000869828 @default.
- W2023335171 creator A5045986378 @default.
- W2023335171 creator A5054733731 @default.
- W2023335171 creator A5067077719 @default.
- W2023335171 creator A5089330653 @default.
- W2023335171 date "2003-01-01" @default.
- W2023335171 modified "2023-10-14" @default.
- W2023335171 title "Inhibition of cryogelation by the novel synthetic peptide (Gly–Arg–Lys–Lys–Thr): recognition site of extra domain A containing fibronectin for heparin in cryogelation" @default.
- W2023335171 cites W1528168357 @default.
- W2023335171 cites W1666259683 @default.
- W2023335171 cites W1834186123 @default.
- W2023335171 cites W1968706274 @default.
- W2023335171 cites W1971834484 @default.
- W2023335171 cites W1973689211 @default.
- W2023335171 cites W1983649348 @default.
- W2023335171 cites W1986098794 @default.
- W2023335171 cites W2014189407 @default.
- W2023335171 cites W2015193010 @default.
- W2023335171 cites W2018089411 @default.
- W2023335171 cites W2051908433 @default.
- W2023335171 cites W2056090437 @default.
- W2023335171 cites W2065277911 @default.
- W2023335171 cites W2072286439 @default.
- W2023335171 cites W2073467797 @default.
- W2023335171 cites W2076546762 @default.
- W2023335171 cites W2083161238 @default.
- W2023335171 cites W2084885576 @default.
- W2023335171 cites W2092709996 @default.
- W2023335171 cites W2096423992 @default.
- W2023335171 cites W2104899331 @default.
- W2023335171 cites W2134389598 @default.
- W2023335171 cites W2146393738 @default.
- W2023335171 cites W2150876393 @default.
- W2023335171 cites W2155676920 @default.
- W2023335171 cites W2327415933 @default.
- W2023335171 cites W2398151412 @default.
- W2023335171 cites W9703484 @default.
- W2023335171 cites W1963641009 @default.
- W2023335171 cites W2094888095 @default.
- W2023335171 doi "https://doi.org/10.1016/s0141-8130(02)00083-1" @default.
- W2023335171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12568929" @default.
- W2023335171 hasPublicationYear "2003" @default.
- W2023335171 type Work @default.
- W2023335171 sameAs 2023335171 @default.
- W2023335171 citedByCount "2" @default.
- W2023335171 crossrefType "journal-article" @default.
- W2023335171 hasAuthorship W2023335171A5000869828 @default.
- W2023335171 hasAuthorship W2023335171A5045986378 @default.
- W2023335171 hasAuthorship W2023335171A5054733731 @default.
- W2023335171 hasAuthorship W2023335171A5067077719 @default.
- W2023335171 hasAuthorship W2023335171A5089330653 @default.
- W2023335171 hasConcept C185592680 @default.
- W2023335171 hasConcept C189165786 @default.
- W2023335171 hasConcept C2777557582 @default.
- W2023335171 hasConcept C2779036427 @default.
- W2023335171 hasConcept C2779281246 @default.
- W2023335171 hasConcept C55493867 @default.
- W2023335171 hasConcept C86492073 @default.
- W2023335171 hasConceptScore W2023335171C185592680 @default.
- W2023335171 hasConceptScore W2023335171C189165786 @default.
- W2023335171 hasConceptScore W2023335171C2777557582 @default.
- W2023335171 hasConceptScore W2023335171C2779036427 @default.
- W2023335171 hasConceptScore W2023335171C2779281246 @default.
- W2023335171 hasConceptScore W2023335171C55493867 @default.
- W2023335171 hasConceptScore W2023335171C86492073 @default.
- W2023335171 hasIssue "4-5" @default.
- W2023335171 hasLocation W20233351711 @default.
- W2023335171 hasLocation W20233351712 @default.
- W2023335171 hasOpenAccess W2023335171 @default.
- W2023335171 hasPrimaryLocation W20233351711 @default.
- W2023335171 hasRelatedWork W1983668447 @default.
- W2023335171 hasRelatedWork W1990931459 @default.
- W2023335171 hasRelatedWork W2080443094 @default.
- W2023335171 hasRelatedWork W2092807678 @default.
- W2023335171 hasRelatedWork W2130281612 @default.
- W2023335171 hasRelatedWork W2415505442 @default.
- W2023335171 hasRelatedWork W2463357419 @default.
- W2023335171 hasRelatedWork W3022435748 @default.
- W2023335171 hasRelatedWork W4230171437 @default.
- W2023335171 hasRelatedWork W183344296 @default.
- W2023335171 hasVolume "31" @default.
- W2023335171 isParatext "false" @default.
- W2023335171 isRetracted "false" @default.
- W2023335171 magId "2023335171" @default.
- W2023335171 workType "article" @default.